FI873593A - Nya applikationsformer foer -interferon. - Google Patents

Nya applikationsformer foer -interferon. Download PDF

Info

Publication number: FI873593A
Authority: FI; Finland
Prior art keywords: applikationsformer; nya; foer; interferon; nya applikationsformer
Prior art date: 1986-08-21

Application number

FI873593A

Other languages

English (en)

Other versions

FI89007B (fi

FI89007C (fi

FI873593A0 (fi

Inventor

Robert Becker

Bernd Kruss

Leonhard Schilk

Original Assignee

Thomae Gmbh Dr K

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-08-21

Filing date

1987-08-20

Publication date

1988-02-22

1987-08-20 Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K

1987-08-20 Publication of FI873593A0 publication Critical patent/FI873593A0/fi

1988-02-22 Publication of FI873593A publication Critical patent/FI873593A/fi

1993-04-30 Publication of FI89007B publication Critical patent/FI89007B/fi

1993-08-10 Application granted granted Critical

1993-08-10 Publication of FI89007C publication Critical patent/FI89007C/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Ophthalmology & Optometry (AREA)
Oil, Petroleum & Natural Gas (AREA)
General Chemical & Material Sciences (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

FI873593A 1986-08-21 1987-08-20 Foerfarande foer framstaellning av nya applikationsformer foer -interferon FI89007C (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE3628468		1986-08-21
DE19863628468 DE3628468A1 (de)	1986-08-21	1986-08-21	Neue applikationsformen fuer (alpha)-interferone

Publications (4)

Publication Number	Publication Date
FI873593A0 FI873593A0 (fi)	1987-08-20
FI873593A true FI873593A (fi)	1988-02-22
FI89007B FI89007B (fi)	1993-04-30
FI89007C FI89007C (fi)	1993-08-10

Family

ID=6307914

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI873593A FI89007C (fi)	1986-08-21	1987-08-20	Foerfarande foer framstaellning av nya applikationsformer foer -interferon

Country Status (14)

Country	Link
US (1)	US4824674A (fi)
EP (1)	EP0258683A3 (fi)
JP (1)	JPS6351338A (fi)
KR (1)	KR880002541A (fi)
AU (1)	AU590958B2 (fi)
CA (1)	CA1313131C (fi)
DE (1)	DE3628468A1 (fi)
DK (1)	DK434087A (fi)
FI (1)	FI89007C (fi)
IL (1)	IL83585A0 (fi)
NO (1)	NO873513L (fi)
NZ (1)	NZ221497A (fi)
PT (1)	PT85561B (fi)
ZA (1)	ZA876166B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5151265A (en) *	1987-11-03	1992-09-29	Genentech, Inc.	Gamma interferon formulation
IL88233A (en) *	1987-11-03	1993-08-18	Genentech Inc	Gamma interferon formulation
GB8813032D0 (en) *	1988-06-02	1988-07-06	Boehringer Ingelheim Int	Antiviral pharmaceutical composition
DE3826055A1 (de) *	1988-07-30	1990-02-01	Boehringer Mannheim Gmbh	Mit reagenz abloesbar impraegnierte traegermatrix
CA2120950A1 (en) *	1991-10-11	1993-04-15	Mark C. Gillies	Treating ophthalmic fibrosis using interferon-alpha
US5863530A (en) *	1991-10-11	1999-01-26	Spruson & Ferguson	Treating ophthalmic fibrosis using interferon-α
US5358708A (en) *	1993-01-29	1994-10-25	Schering Corporation	Stabilization of protein formulations
DE19508029C2 (de) *	1995-03-07	1997-10-09	Richard Prof Dr Sueverkruep	Darreichungsform zur äußerlichen Applikation von ophthalmischen Arzneistoffen und Verfahren zur Herstellung derselben
JP2002518433A (ja) *	1998-06-22	2002-06-25	ユニハートコーポレーション	天然型インターフェロンの徐放用絆創膏
US20030206945A1 (en) *	2000-12-20	2003-11-06	Giulio Tarro	Sticking plaster for controlled release of natural interferon
AR034749A1 (es) *	2001-07-09	2004-03-17	Schering Ag	Formulaciones de interferon beta humano
ATE457707T1 (de)	2001-12-04	2010-03-15	Active Implants Corp	Kissenlagerungsimplantate für lasttragende anwendungen
KR20190120439A (ko)	2010-11-08	2019-10-23	제넨테크, 인크.	피하 투여용 항―ｉｌ―6 수용체 항체
US20160114048A1 (en) *	2013-05-16	2016-04-28	Universiteit Antwerpen	Thermolabile drug release formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1055895A (en) *	1963-12-10	1967-01-18	Glaxo Lab Ltd	Interferon purification
DE2017373A1 (de) *	1969-04-15	1971-04-22	Orsymonde S A , Paris	Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
SE374272B (fi) *	1973-08-31	1975-03-03	D A Safwat
US3932617A (en) *	1974-05-24	1976-01-13	The Upjohn Company	Interferon induction
US4363634A (en) *	1980-07-18	1982-12-14	Akzona Incorporated	Glass support coated with synthetic polymer for bioprocess
US4357142A (en) *	1980-07-18	1982-11-02	Akzona Incorporated	Glass support coated with synthetic polymer for bioprocess
US4414147A (en) *	1981-04-17	1983-11-08	Massachusetts Institute Of Technology	Methods of decreasing the hydrophobicity of fibroblast and other interferons
JPS5821691A (ja) *	1981-07-29	1983-02-08	Mochida Pharmaceut Co Ltd	α−及びβ−インタ−フェロンの精製方法
JPS5892621A (ja) *	1981-11-28	1983-06-02	Sunstar Inc	インタ−フエロンを安定に配合した製剤
EP0082481B2 (en) *	1981-12-23	1990-09-12	Schering Corporation	Stabilised alpha-interferon formulations and their preparation
JPS59181224A (ja) *	1983-03-29	1984-10-15	Sumitomo Chem Co Ltd	安定なインタ−フエロン製剤の製法
US4680175A (en) *	1984-02-07	1987-07-14	Interferon Sciences, Inc.	Interferon administration vehicles
DE3513288A1 (de) *	1985-04-13	1986-10-23	Dr. Karl Thomae Gmbh, 7950 Biberach	Verfahren und vorrichtung zur beaufschlagung von augenstaebchen mit wirkstoffloesungen oder -suspensionen

1986
- 1986-08-21 DE DE19863628468 patent/DE3628468A1/de not_active Ceased
1987
- 1987-08-08 EP EP87111493A patent/EP0258683A3/de not_active Withdrawn
- 1987-08-19 NZ NZ221497A patent/NZ221497A/xx unknown
- 1987-08-19 IL IL83585A patent/IL83585A0/xx unknown
- 1987-08-19 CA CA000544820A patent/CA1313131C/en not_active Expired - Fee Related
- 1987-08-20 JP JP62207341A patent/JPS6351338A/ja active Pending
- 1987-08-20 DK DK434087A patent/DK434087A/da not_active Application Discontinuation
- 1987-08-20 PT PT85561A patent/PT85561B/pt not_active IP Right Cessation
- 1987-08-20 KR KR870009090A patent/KR880002541A/ko not_active Application Discontinuation
- 1987-08-20 FI FI873593A patent/FI89007C/fi not_active IP Right Cessation
- 1987-08-20 NO NO873513A patent/NO873513L/no unknown
- 1987-08-20 ZA ZA876166A patent/ZA876166B/xx unknown
- 1987-08-21 US US07/088,187 patent/US4824674A/en not_active Expired - Fee Related
- 1987-08-21 AU AU77307/87A patent/AU590958B2/en not_active Ceased

Also Published As

Publication number	Publication date
US4824674A (en)	1989-04-25
PT85561A (de)	1987-09-01
FI89007B (fi)	1993-04-30
AU7730787A (en)	1988-02-25
AU590958B2 (en)	1989-11-23
EP0258683A2 (de)	1988-03-09
FI89007C (fi)	1993-08-10
KR880002541A (ko)	1988-05-09
DK434087A (da)	1988-02-22
EP0258683A3 (de)	1988-09-07
NO873513D0 (no)	1987-08-20
NZ221497A (en)	1990-04-26
CA1313131C (en)	1993-01-26
PT85561B (pt)	1990-05-31
FI873593A0 (fi)	1987-08-20
NO873513L (no)	1988-02-22
ZA876166B (en)	1989-05-30
DK434087D0 (da)	1987-08-20
DE3628468A1 (de)	1988-03-03
IL83585A0 (en)	1988-01-31
JPS6351338A (ja)	1988-03-04

Publication	Publication Date	Title
FI873977A0 (fi)	1987-09-14	Nya (1h-imidazol-1-ylmetyl) substituerande bensimidazolderivat.
FI872878A0 (fi)	1987-06-30	Foerfarande foer framstaellning av nya algininsyraestrar.
FI874287A0 (fi)	1987-09-30	Nya lymfokinpeptider.
FI873704A (fi)	1988-02-29	Nya ksantinderivat.
FI870871A0 (fi)	1987-02-27	Foerfarande foer framstaellning av nya terapeutiskt anvaendbara peptidderivat.
FI871406A0 (fi)	1987-03-31	Foerfarande foer framstaellning av nya aminosyraderivat.
FI875438A0 (fi)	1987-12-10	Foerfarande foer framstaellning av nya pyrrolobenzimidazoler.
FI873193A (fi)	1988-01-24	Nya 18-fenylestranderivat.
FI873593A0 (fi)	1987-08-20	Nya applikationsformer foer -interferon.
FI883257A (fi)	1988-07-07	Nya peptider.
FI872571A (fi)	1987-12-13	Nya antracykliner.
FI871094A (fi)	1987-09-13	Nya monocykliska estrar.
FI893155A (fi)	1989-06-28	Nya foereningar.
FI872489A (fi)	1987-12-07	Foerfarande foer framstaellning av nya aralkylimidazolderivat.
FI875766A (fi)	1988-07-01	Foerfarande foer framstaellning av nya pyrimidinderivat.
FI872735A0 (fi)	1987-06-18	Nya vacciner.
FI870626A (fi)	1987-08-15	Nya polymerbarriaerblandningar.
FI872527A (fi)	1987-12-07	Foerfarande foer framstaellning av nya peptider.
FI875130A0 (fi)	1987-11-19	Nya benzokinoliner.
FI870091A0 (fi)	1987-01-12	Nya biocider.
FI874885A0 (fi)	1987-11-04	Foerfarande foer framstaellning av nya kondenserade cykliska triazolderivat.
FI884633A (fi)	1988-10-07	Nya malonsyraderivatfoereningar.
FI860837A (fi)	1987-08-28	Nya alfa-aminoalkyl-alfa-alkylfenylacetonitriler.
FI870872A0 (fi)	1987-02-27	Nya foereningar.
FI862751A0 (fi)	1986-06-27	Nya makromolekyler.

Legal Events

Date	Code	Title	Description
1993-04-01	BB	Publication of examined application
1995-03-13	MM	Patent lapsed
2004-08-31	MM	Patent lapsed	Owner name: DR. KARL THOMAE GESELLSCHAFT MIT